Adrian Gillespie
Chief Executive Officer @ Scottish Enterprise
Glasgow, United Kingdom
Adrian Gillespie is a grant investor at Scottish Enterprise in Glasgow focused on Energy and Medical. Adrian Gillespie is the Chief Executive Officer at Scottish Enterprise. He attended University of Strathclyde.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Adrian Gillespie invests in
Stages Adrian Gillespie invests in
Countries Adrian Gillespie invests in
Investment Focus
Industry
- Energy 1 (20%)
- Medical 1 (20%)
- Automotive 1 (20%)
- Health Care 1 (20%)
- Therapeutics 1 (20%)
Stage
- Grant 4 (80%)
- Debt Financing 1 (20%)
Country
- United States 2 (40%)
- United Kingdom 2 (40%)
- France 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Launchpad is developing technology that will allow products to be delivered in days rather than months. The company is creating a user-friendly system of advanced software and autonomous hardware that will allow for a streamlined AI-driven digital thread from product CAD to actual product assembly. Launchpad's digitool is a networkedautomation solution that can perform a wide range of assembly tasks, such as pick and place, fastening, dispensing, and more, using only a product CAD file. The company's mission to enable manufacturing's future by increasing automation and improving utilization | $2.5M / Grant / Oct 15, 2025 | |
|
|
Allied Vehicles offers a wide collection of special purpose vehicles and automotive for people with disabilities. | $1.7M / Grant / Jul 28, 2023 | |
|
|
ETZ is a pioneer in the field of net zero energy transition and a net exporter of goods, services, technology, and expertise. | $4M / Grant / Mar 17, 2023 | |
|
|
Mangata is a telecommunication company that specializes in satellite and wired communication services. It was founded in 2020 and is headquartered in Phoenix, Arizona. | $102.1M / Debt Financing / Dec 05, 2022 | |
|
|
Valneva is a pharmaceutical company developing prophylactic vaccines to treat infectious diseases. The company focused on developing and commercializing prophylactic vaccines for infectious diseases with significant unmet medical needs. Valneva has leveraged its expertise and capabilities both to commercialize two vaccines successfully and torapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus, and COVID-19. | $27.2M / Grant / Feb 21, 2022 |
Co-Investors
About Scottish Enterprise
Scottish Enterprise is Scotland's main economic development agency and a non-departmental public body of the Scottish Government. The firm wants to stimulate Scotland’s economic ambition – creating an innovative, high-wage and highly productive economy with a competitive, international market presence and a focus on high value opportunities.Scottish Enterprise partners with the public and private sectors to identify and exploit the best opportunities to deliver a significant, lasting effect on the Scottish economy.
Scottish Enterprise Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Graeme Waddell
Board Member
|
|||
|
Jim McDonald
Board Member
|
|||
|
Adrian Gillespie
Chief Executive Officer
|
|||
|
David Hartley
Head of Creative Industries
|
|||
|
David McHoul
Innovation Specialist
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Adrian Gillespie invest in?
Adrian Gillespie invests primarily in Energy, Medical and Automotive startups, most often at Grant and Debt Financing stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Adrian Gillespie last invest?
The most recent investment recorded for Adrian Gillespie closed in Oct 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!